In conclusion, the SCAMP1/miR‐499a‐5p/LMX1A/NLRC5 axis serves as a critical regulator of tumourigenesis and progression of glioma, providing a novel therapeutic strategy for glioma treatment. This evidence concerns the gene LMX1A and central nervous system cancer.